Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $442.44 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $162.61 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $123.19 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $66.90 | 4 | $0 (2024) |
| PFIZER INC. | $38.65 | 3 | $0 (2024) |
| Novo Nordisk Inc | $19.56 | 1 | $0 (2022) |
| Mission Pharmacal Company | $16.59 | 1 | $0 (2017) |
| Eisai Inc. | $14.94 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.35 | 5 | E.R. Squibb & Sons, L.L.C. ($66.90) |
| 2022 | $19.56 | 1 | Novo Nordisk Inc ($19.56) |
| 2021 | $14.94 | 1 | Eisai Inc. ($14.94) |
| 2018 | $11.88 | 1 | PFIZER INC. ($11.88) |
| 2017 | $315.71 | 4 | Covidien LP ($162.61) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.62 | General |
| Category: Oncology | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Oncology | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: Oncology | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Oncology | ||||||
| 07/31/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes | ||||||
| 09/17/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: Oncology | ||||||
| 08/02/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/22/2017 | Covidien LP | Nellcor (Device) | Food and Beverage | In-kind items and services | $162.61 | General |
| Category: Breathing Systems | ||||||
| 11/16/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $123.19 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2017 | Mission Pharmacal Company | CitraNatal (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Prenatal Vitamin & Mineral | ||||||
| 02/23/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 294 | 536 | $541,284 | $60,109 |
| 2022 | 5 | 401 | 860 | $994,867 | $97,274 |
| 2021 | 4 | 415 | 901 | $1.2M | $125,313 |
| 2020 | 5 | 240 | 468 | $516,605 | $58,778 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 116 | 234 | $351,357 | $37,683 | 10.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 111 | $79,751 | $9,960 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 118 | $61,536 | $6,816 | 11.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 49 | 51 | $36,342 | $4,380 | 12.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 22 | $12,298 | $1,271 | 10.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 149 | 396 | $671,616 | $65,816 | 9.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 89 | 209 | $165,319 | $16,159 | 9.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 155 | $85,715 | $8,333 | 9.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 63 | 63 | $51,534 | $4,983 | 9.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 35 | 37 | $20,683 | $1,982 | 9.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 196 | 543 | $919,704 | $93,098 | 10.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 101 | 235 | $185,780 | $18,849 | 10.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 50 | 50 | $77,200 | $7,621 | 9.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 68 | 73 | $59,534 | $5,745 | 9.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 73 | 195 | $319,656 | $34,484 | 10.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 70 | 163 | $119,201 | $13,461 | 11.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 41 | 42 | $36,612 | $6,052 | 16.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 37 | 37 | $26,922 | $3,015 | 11.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 31 | $14,214 | $1,766 | 12.4% |
About Dr. Sagar Patel, M.D
Dr. Sagar Patel, M.D is a Internal Medicine healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1326319096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sagar Patel, M.D has received a total of $442.44 in payments from pharmaceutical and medical device companies, with $80.35 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($442.44).
As a Medicare-enrolled provider, Patel has provided services to 1,350 Medicare beneficiaries, totaling 2,765 services with total Medicare billing of $341,475. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Lafayette, IN
- Active Since 01/25/2012
- Last Updated 01/28/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326319096
Products in Payments
- Nellcor (Device) $162.61
- UTIBRON (Drug) $123.19
- OPDIVO (Biological) $66.90
- ELIQUIS (Drug) $26.77
- Rybelsus (Drug) $19.56
- CitraNatal (Drug) $16.59
- Lenvima (Drug) $14.94
- CHANTIX (Drug) $11.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lafayette
Steven Steinhubl, Md, MD
Internal Medicine — Payments: $172,128
Dr. Eric Trawick, Md, MD
Internal Medicine — Payments: $83,507
Dr. Brent Rochon, Md, MD
Internal Medicine — Payments: $23,953
Hector Robles, Md, MD
Internal Medicine — Payments: $23,742
Dr. Robert Russell, Md, MD
Internal Medicine — Payments: $18,283
Nethuja Salagundla, M.d, M.D
Internal Medicine — Payments: $17,501